SOLIGENIX, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$827.68 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2020-11-12
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-09-30 was -$691.64K, a 443.84% decline year-over-year.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-06-30 was -$515.58K, a 137.26% decline year-over-year.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-03-31 was $379.54K.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-12-31 was $458.84K, a 72.35% increase year-over-year.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $1.97M, a 93.00% increase from fiscal 2018.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $1.02M, a 166.52% increase from fiscal 2017.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $382.71K.
- SOLIGENIX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was -$1.48M, a 207.17% decline from fiscal 2015.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$691.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$1.21M derived: sum of 2 quarters · filed 2020-11-12 | -$827.68K 10-Q · filed 2020-11-12 | -$368.84K derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-06-30 | -$515.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$136.03K 10-Q · filed 2020-08-14 | $322.80K derived: sum of 3 quarters · filed 2020-08-14 | $523.95K derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-03-31 | $379.54K 10-Q · filed 2020-05-15 | $838.38K derived: sum of 2 quarters · filed 2020-05-15 | $1.04M derived: sum of 3 quarters · filed 2020-11-12 | $2.42M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-12-31 | $458.84K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $659.99K derived: sum of 2 quarters · filed 2020-11-12 | $2.04M derived: sum of 3 quarters · filed 2020-11-12 | $1.97M 10-K · filed 2020-03-30 |
| 2019-09-30 | $201.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.59M derived: sum of 2 quarters · filed 2020-11-12 | $1.51M 10-Q · filed 2020-11-12 | $1.78M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.31M 10-Q · filed 2020-08-14 | $1.57M derived: sum of 3 quarters · filed 2020-08-14 | $1.95M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$75.34K 10-Q · filed 2020-05-15 | $190.88K derived: sum of 2 quarters · filed 2020-05-15 | $565.44K derived: sum of 3 quarters · filed 2020-05-15 | $481.14K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $266.22K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $640.78K derived: sum of 2 quarters · filed 2020-03-30 | $556.48K derived: sum of 3 quarters · filed 2020-03-30 | $1.02M 10-K · filed 2020-03-30 |
| 2018-09-30 | $374.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $290.26K derived: sum of 2 quarters · filed 2019-11-12 | $753.77K 10-Q · filed 2019-11-12 | $1.08M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$84.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $379.21K 10-Q · filed 2019-08-13 | $707.20K derived: sum of 3 quarters · filed 2019-08-13 | $182.16K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $463.51K 10-Q · filed 2019-05-14 | $791.51K derived: sum of 2 quarters · filed 2019-05-14 | $266.46K derived: sum of 3 quarters · filed 2019-05-14 | $940.47K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$197.04K derived: sum of 2 quarters · filed 2019-03-26 | $476.96K derived: sum of 3 quarters · filed 2019-03-26 | $382.71K 10-K · filed 2019-03-26 |
| 2017-09-30 | -$525.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $148.97K derived: sum of 2 quarters · filed 2018-11-09 | $54.71K 10-Q · filed 2018-11-09 | -$1.63M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $674.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $579.76K 10-Q · filed 2018-08-08 | -$1.10M derived: sum of 3 quarters · filed 2018-08-08 | -$1.08M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$94.25K 10-Q · filed 2018-05-11 | -$1.78M derived: sum of 2 quarters · filed 2018-05-11 | -$1.76M derived: sum of 3 quarters · filed 2018-05-11 | -$1.82M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.66M derived: sum of 2 quarters · filed 2018-03-15 | -$1.73M derived: sum of 3 quarters · filed 2018-03-15 | -$1.48M 10-K · filed 2018-03-15 |
| 2016-09-30 | $18.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$45.95K derived: sum of 2 quarters · filed 2017-11-06 | $206.88K 10-Q · filed 2017-11-06 | $239.40K derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$64.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $188.04K 10-Q · filed 2017-08-11 | $220.55K derived: sum of 3 quarters · filed 2017-08-11 | |
| 2016-03-31 | $252.84K 10-Q · filed 2017-05-11 | $285.35K derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2015-12-31 | $32.52K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $1.38M 10-K · filed 2017-03-27 | ||
| 2015-09-30 | $1.34M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |